FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149506092> ?p ?o ?g. }

• W2149506092 abstract "Abstract Background To conserve laryngeal function and elevate living quality of laryngeal squamous cell carcinoma (LSCC) patients, we designed antisense oligodeoxynucleotides (AS-ODNs) to reduce expression of ATM and to enhance the apoptosis of hep-2 (Human epidermoid laryngeal carcinoma) cells to radiation in vitro and in vivo. Methods The expression of ATM mRNA and protein in hep-2 cells were examined by real-time quantitative PCR and western blotting respectively. Clonogenic survival assay was carried out to detect the survival ability of hep-2 cells after irradiation, and analyzed the cell apoptosis by flow cytometry. The volume of solid tumors was measured, while TUNEL assay and western blotting used to analyze cell apoptosis and protein expression after irradiation. Results The relative ATM mRNA and protein expression in hep-2 cells treated with ATM AS-ODNs were decreased to 11.03 ± 2.51% and 48.14 ± 5.53% of that in untreated cells respectively (P <0.05). After irradiation, the survival fraction (SF) of cells treated with ATM AS-ODNs was lower than that of other groups at the same dose of radiation (P < 0.05). The inhibition rate in hep-2 cells solid tumor exposed to X-ray alone was 5.95 ± 4.52%, while it was 34.28 ± 2.43% in the group which irradiated in combination with the treatment of ATM AS-ODNs (P < 0.05). The apoptotic index for the group irradiated in combination with ATM AS-ODNs injection was 17.12 ± 4.2%, which was significantly higher than that of others (P < 0.05). Conclusion AS-ODNs of ATM reduce ATM expression and enhance hep-2 cells apoptosis to radiation in vitro and in vivo." @default.
• W2149506092 created "2016-06-24" @default.
• W2149506092 creator A5013052976 @default.
• W2149506092 creator A5036190975 @default.
• W2149506092 creator A5053326897 @default.
• W2149506092 creator A5077702516 @default.
• W2149506092 creator A5088816687 @default.
• W2149506092 date "2011-04-17" @default.
• W2149506092 modified "2023-10-16" @default.
• W2149506092 title "Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice" @default.
• W2149506092 cites W1588736504 @default.
• W2149506092 cites W1853857034 @default.
• W2149506092 cites W1968390725 @default.
• W2149506092 cites W1976435772 @default.
• W2149506092 cites W1981736179 @default.
• W2149506092 cites W2002843346 @default.
• W2149506092 cites W2008743975 @default.
• W2149506092 cites W2019379230 @default.
• W2149506092 cites W2022686124 @default.
• W2149506092 cites W2028307977 @default.
• W2149506092 cites W2043798203 @default.
• W2149506092 cites W2047529067 @default.
• W2149506092 cites W2048875971 @default.
• W2149506092 cites W2059971436 @default.
• W2149506092 cites W2068727486 @default.
• W2149506092 cites W2076173823 @default.
• W2149506092 cites W2082559623 @default.
• W2149506092 cites W2088013332 @default.
• W2149506092 cites W2144813617 @default.
• W2149506092 cites W2160379344 @default.
• W2149506092 cites W2164520769 @default.
• W2149506092 doi "https://doi.org/10.1186/1756-9966-30-43" @default.
• W2149506092 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3097000" @default.
• W2149506092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21496344" @default.
• W2149506092 hasPublicationYear "2011" @default.
• W2149506092 type Work @default.
• W2149506092 sameAs 2149506092 @default.
• W2149506092 citedByCount "7" @default.
• W2149506092 countsByYear W21495060922012 @default.
• W2149506092 countsByYear W21495060922013 @default.
• W2149506092 countsByYear W21495060922014 @default.
• W2149506092 countsByYear W21495060922017 @default.
• W2149506092 countsByYear W21495060922018 @default.
• W2149506092 countsByYear W21495060922021 @default.
• W2149506092 crossrefType "journal-article" @default.
• W2149506092 hasAuthorship W2149506092A5013052976 @default.
• W2149506092 hasAuthorship W2149506092A5036190975 @default.
• W2149506092 hasAuthorship W2149506092A5053326897 @default.
• W2149506092 hasAuthorship W2149506092A5077702516 @default.
• W2149506092 hasAuthorship W2149506092A5088816687 @default.
• W2149506092 hasBestOaLocation W21495060921 @default.
• W2149506092 hasConcept C104317684 @default.
• W2149506092 hasConcept C117262875 @default.
• W2149506092 hasConcept C1491633281 @default.
• W2149506092 hasConcept C150903083 @default.
• W2149506092 hasConcept C153911025 @default.
• W2149506092 hasConcept C154113507 @default.
• W2149506092 hasConcept C185592680 @default.
• W2149506092 hasConcept C190283241 @default.
• W2149506092 hasConcept C196795494 @default.
• W2149506092 hasConcept C207001950 @default.
• W2149506092 hasConcept C2776415932 @default.
• W2149506092 hasConcept C502942594 @default.
• W2149506092 hasConcept C54355233 @default.
• W2149506092 hasConcept C553184892 @default.
• W2149506092 hasConcept C55493867 @default.
• W2149506092 hasConcept C85265743 @default.
• W2149506092 hasConcept C86803240 @default.
• W2149506092 hasConceptScore W2149506092C104317684 @default.
• W2149506092 hasConceptScore W2149506092C117262875 @default.
• W2149506092 hasConceptScore W2149506092C1491633281 @default.
• W2149506092 hasConceptScore W2149506092C150903083 @default.
• W2149506092 hasConceptScore W2149506092C153911025 @default.
• W2149506092 hasConceptScore W2149506092C154113507 @default.
• W2149506092 hasConceptScore W2149506092C185592680 @default.
• W2149506092 hasConceptScore W2149506092C190283241 @default.
• W2149506092 hasConceptScore W2149506092C196795494 @default.
• W2149506092 hasConceptScore W2149506092C207001950 @default.
• W2149506092 hasConceptScore W2149506092C2776415932 @default.
• W2149506092 hasConceptScore W2149506092C502942594 @default.
• W2149506092 hasConceptScore W2149506092C54355233 @default.
• W2149506092 hasConceptScore W2149506092C553184892 @default.
• W2149506092 hasConceptScore W2149506092C55493867 @default.
• W2149506092 hasConceptScore W2149506092C85265743 @default.
• W2149506092 hasConceptScore W2149506092C86803240 @default.
• W2149506092 hasIssue "1" @default.
• W2149506092 hasLocation W21495060921 @default.
• W2149506092 hasLocation W21495060922 @default.
• W2149506092 hasLocation W21495060923 @default.
• W2149506092 hasLocation W21495060924 @default.
• W2149506092 hasOpenAccess W2149506092 @default.
• W2149506092 hasPrimaryLocation W21495060921 @default.
• W2149506092 hasRelatedWork W2053020665 @default.
• W2149506092 hasRelatedWork W2348513565 @default.
• W2149506092 hasRelatedWork W2350064735 @default.
• W2149506092 hasRelatedWork W2350466793 @default.
• W2149506092 hasRelatedWork W2373007462 @default.
• W2149506092 hasRelatedWork W2390532320 @default.
• W2149506092 hasRelatedWork W2608427804 @default.
• W2149506092 hasRelatedWork W3028704232 @default.

• next